-
Axis Capital (AXS) Tops Q4 EPS by 13c
-
BofA Securities Downgrades AXIS Capital (AXS) to Neutral
-
Mizuho Starts AXIS Capital (AXS) at Outperform
-
AXIS Capital (AXS) PT Raised to $121 at Keefe, Bruyette & Woods
-
Axis Capital (AXS) Tops Q3 EPS by 38c
-
Goldman Sachs Starts AXIS Capital (AXS ) at Neutral
-
Wells Fargo Upgrades AXIS Capital (AXS) to Overweight
-
Ryan Specialty launches $400 million reinsurance vehicle with AXIS
-
AXIS Capital launches new business unit for capacity solutions
-
Axis Capital (AXS) Tops Q2 EPS by 36c
-
AXIS Capital (AXS) PT Raised to $130 at TD Cowen on 'Solid Growth Prospects'
-
AXIS Capital (AXS) PT Raised to $118 at KBW as 'Solid Execution Continues'
-
Axis Capital (AXS) Tops Q1 EPS by 48c
-
AXIS Capital (AXS) PT Raised to $120 at KBW as 'Success Breeds Multiple Expansion'
-
TD Cowen Reiterates Buy Rating on AXIS Capital (AXS) as 'Management Meeting Affirms Strong 2025 Outlook'
-
AXIS Capital (AXS) PT Raised to $118 at Keefe, Bruyette & Woods
-
Axis Capital (AXS) Declares Dividends, Announces New Share Buyback
-
TD Cowen Reiterates Buy Rating on AXIS Capital (AXS): 'AXS's Valuation is Compelling'
-
AXIS Capital (AXS) PT Raised to $115 at Keefe, Bruyette & Woods; 'Adjusting EPS for LPT'
-
KBW Reiterates Outperform Rating on AXIS Capital (AXS)
-
JMP Securities Reiterates Market Perform Rating on AXIS Capital (AXS)
-
TD Cowen Reiterates Buy Rating on AXIS Capital (AXS) Following 'Strong Quarter Across the Board'
-
Axis Capital (AXS) Tops Q4 EPS by 40c
-
BMO Capital Starts AXIS Capital (AXS) at Market Perform
-
Wells Fargo Upgrades AXIS Capital (AXS) to Equal Weight
-
AXIS Capital (AXS) PT Raised to $127 at TD Cowen
-
AXIS Capital (AXS) PT Raised to $96 at Keefe, Bruyette & Woods
-
Axis Capital (AXS) Tops Q3 EPS by 20c
-
Axis Capital (AXS) Announces Leadership Appointments for Irish Legal Entities
-
TD Cowen Starts Coverage on AXIS Capital (AXS) at Buy
-
Axis Capital (AXS): Sara Mitchell to Succeed Mark Gregory as AXIS Head of Global Markets
-
Axis Capital (AXS) Appoints Pranav Shroff to Lead Life Sciences in North America
-
AXIS Capital (AXS) PT Raised to $88 at Keefe, Bruyette & Woods
-
AXIS Capital (AXS) PT Raised to $88 at Jefferies
-
Axis Capital (AXS) Tops Q2 EPS by 35c
-
Keefe, Bruyette & Woods Reiterates Outperform Rating on AXIS Capital (AXS)

